News from omeros corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Bloomberg:RTRKS,RICS:RTRKS)

May 11, 2015, 16:06 ET

Omeros Corporation Reports First Quarter 2015 Financial Results

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule...

May 05, 2015, 07:00 ET

Omeros Corporation to Announce First Quarter 2015 Financial Results on May 11, 2015

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and...

Apr 14, 2015, 07:00 ET

European Regulatory Authority Approves Clinical Investigator's Request for Compassionate Use with Omeros Corporation's OMS721

 Omeros Corporation (NASDAQ: OMER) today announced that the presiding European regulatory authority has approved the company's investigational...

Apr 09, 2015, 16:31 ET

Omeros to Present at the 14th Annual Needham Healthcare Conference

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...

Apr 02, 2015, 08:15 ET
Omeros logo

Omeros Corporation Announces the U.S. Commercial Launch of Omidria™

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein...

Mar 16, 2015, 16:05 ET

Omeros Corporation Reports Fourth Quarter and Year-End 2014 Financial Results

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...

Mar 09, 2015, 18:03 ET

Omeros Corporation to Announce Fourth Quarter and Full-Year 2014 Financial Results on March 16, 2015

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...

Feb 19, 2015, 07:00 ET

Omeros Corporation's Phase 2 OMS721 Trial Resulting in Extended Access for Compassionate Use

Omeros Corporation (NASDAQ: OMER) today announced that it has completed dosing of the low-dose cohort of patients in its ongoing Phase 2 clinical...

Feb 03, 2015, 17:01 ET

Omeros Closes $84 Million Public Offering of Common Stock and Pre-Funded Warrants

Omeros Corporation (NASDAQ: OMER) today announced that it has closed the underwritten public offering that was priced and allocated to investors on...

Jan 29, 2015, 08:32 ET

Omeros Prices $75 Million Public Offering of Common Stock and Pre-Funded Warrants

Omeros Corporation (NASDAQ: OMER) today announced that it has priced an underwritten public offering of 2,995,506 shares of its common stock at a...

Jan 28, 2015, 16:01 ET

Omeros Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

 Omeros Corporation (NASDAQ: OMER) today announced its intention to offer, subject to market and other conditions, shares of its common...

Nov 19, 2014, 07:00 ET

OMS721 Inhibits Thrombus Formation in Sera from aHUS Patients

 Omeros Corporation (NASDAQ: OMER) today announced positive data using OMS721, the lead human monoclonal antibody for its mannan-binding...

Nov 10, 2014, 16:02 ET

Omeros Corporation Reports Third Quarter 2014 Financial Results

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein...

Nov 06, 2014, 07:00 ET

Omeros Announces Positive Data for MASP-2 Inhibitor in Experimental Model of Stroke

Omeros Corporation (NASDAQ: OMER) today announced positive data using a derivative of OMS721 in a well-established animal model of stroke. OMS721...

Nov 04, 2014, 07:00 ET

Omeros Corporation to Announce Third Quarter 2014 Financial Results on November 10, 2014

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein...

Oct 30, 2014, 07:00 ET

Omidria™ Granted Pass-Through Reimbursement Status from CMS

Omeros Corporation (NASDAQ: OMER) announced today that it has received transitional pass-through status for its lead product Omidria™...

Oct 21, 2014, 07:00 ET

Omeros Provides Update on PDE10 Inhibitor Program

 Omeros Corporation (NASDAQ: OMER) today provided an update on OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor in development for...

Aug 11, 2014, 16:03 ET

Omeros Corporation Reports Second Quarter 2014 Financial Results

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein...

Aug 08, 2014, 07:00 ET

Omeros to Present at the Wedbush PacGrow 2014 Life Sciences Management Access Conference

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on...

Jun 02, 2014, 07:00 ET

Omeros Receives FDA Approval of Omidria™ for Use in Cataract and Other Intraocular Lens Replacement Procedures

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved Omidria™ (phenylephrine and...